S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
"Prepare for Five Years of Famine" (Ad)
OTCMKTS:INBP

Integrated BioPharma - INBP Stock Forecast, Price & News

$0.55
+0.05 (+10.02%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.55
$0.55
50-Day Range
$0.41
$0.72
52-Week Range
$0.27
$1.18
Volume
500 shs
Average Volume
13,020 shs
Market Capitalization
$16.44 million
P/E Ratio
2.61
Dividend Yield
N/A
Price Target
N/A

About Integrated BioPharma

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

INBP Stock News Headlines

Integrated BioPharma Announces Change in Directors
Integrated BioPharma GAAP EPS of $0.03, revenue of $14.6M
Biotech Rallies On Bullish Earnings
Integrated BioPharma Inc.
Integrated BioPharma Announces Upgrade to OTCQX
Integrated BioPharma: Strong Growth For Less Than A 5 P/E
Integrated BioPharma, Inc. (INBP)
See More Headlines
Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

INBP Company Calendar

Today
8/14/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INBP
Employees
147
Year Founded
N/A

Profitability

Net Income
$8.01 million
Pretax Margin
8.55%

Debt

Sales & Book Value

Annual Sales
$63.56 million
Cash Flow
$0.30 per share
Book Value
$0.48 per share

Miscellaneous

Free Float
8,626,000
Market Cap
$16.44 million
Optionable
Not Optionable
Beta
0.50

Key Executives

  • Mr. E. Gerald Kay (Age 86)
    Founder, Exec. Chairman & Pres
    Comp: $240.65k
  • Ms. Riva Kay Sheppard (Age 55)
    Co-CEO & Director
    Comp: $225.92k
  • Ms. Christina Kay (Age 52)
    Co-CEO & Director
    Comp: $226.99k
  • Ms. Dina L. Masi (Age 61)
    Sr. VP, CFO & Sec.
    Comp: $251.88k
  • Mr. Jamie E. Levey
    Head of Investor Relations
  • Dr. Geoffrey C. Schild Ph.D. (Age 85)
    OBE, CBE, Chief Scientific Officer of iBioPharma
  • Dr. Orn Adalsteinsson Ph.D.
    Chief Exec. Officer of Nucycle Therapy Inc and Pres of Nucycle Therapy Inc
  • Mr. Nickolas Palin (Age 74)
    Pres of Nutraceutical Segment
  • Mr. Robert L. Erwin (Age 69)
    Pres of iBioPharma













INBP Stock - Frequently Asked Questions

How have INBP shares performed in 2022?

Integrated BioPharma's stock was trading at $1.04 at the start of the year. Since then, INBP stock has decreased by 47.2% and is now trading at $0.5490.
View the best growth stocks for 2022 here
.

What is Integrated BioPharma's stock symbol?

Integrated BioPharma trades on the OTCMKTS under the ticker symbol "INBP."

How do I buy shares of Integrated BioPharma?

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integrated BioPharma's stock price today?

One share of INBP stock can currently be purchased for approximately $0.55.

How much money does Integrated BioPharma make?

Integrated BioPharma (OTCMKTS:INBP) has a market capitalization of $16.44 million and generates $63.56 million in revenue each year. The company earns $8.01 million in net income (profit) each year or $0.21 on an earnings per share basis.

How many employees does Integrated BioPharma have?

The company employs 147 workers across the globe.

How can I contact Integrated BioPharma?

Integrated BioPharma's mailing address is 225 LONG AVENUE BUILDING 15, HILLSIDE NJ, 07205. The official website for the company is www.integratedbiopharma.com. The company can be reached via phone at (888) 319-6962, via email at investors@ibiopharma.com, or via fax at 973-926-1735.

This page (OTCMKTS:INBP) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.